Valsartan and Hydrochlorothiazide
- Product NDC
- 70934-594
- 11-digit product format
- 709340594
- Labeler code
- 70934
- Product ID
- 70934-594_ab96c10e-b19e-2d7d-e053-2995a90a4f74
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Valsartan and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA203145
- Marketing category
- ANDA
- Marketing start
- 2020-03-05
- Marketing end
- 0000-00-00
- Substance
- VALSARTAN; HYDROCHLOROTHIAZIDE
- Active strength
- 160 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-594-30 | 70934059430 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-594-30) | 30 tablet | 2020-03-05 | 0000-00-00 | No | No | Current |